Analysis of public GEO datasets showed that AURKA is overexpressed in patient-derived myeloma samples compared with normal controls, with especially elevated expression in plasma cell leukemia, where higher AURKA levels may be linked to worse outcomes. This evidence concerns the gene AURKA and plasma cell leukemia.